AI aims to slash unnecessary prostate biopsies
NCT ID NCT06589154
Summary
This study tested a new artificial intelligence (AI) tool designed to help doctors better diagnose prostate cancer. The tool combines information from a blood test and an MRI scan to more accurately tell if a man needs a biopsy. The goal is to reduce the number of unnecessary, invasive biopsies for men whose prostate-specific antigen (PSA) levels are in a confusing middle range.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
-
Jiangsu Provincial People's Hospita
Nanjing, Jiangsu, 210029, China
-
Ningbo No. 1 Hospita
Ningbo, Zhejiang, 315010, China
-
Northern Jiangsu People's Hospita
Yangzhou, Jiangsu, 225001, China
-
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, 201209, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
-
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.